Evidence map›Paper›PMID 41847177›Full record

ReviewInternational journal of nanomedicine2026

Nano-Immunomodulators for Directing Macrophage Fate to Enhance Peripheral Nerve Repair: Advances, Challenges, and Translational Perspectives.

Shaoyan Shi, Xingxing Yu, Xuehai Ou, Qian Wang, Dong Hu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaoyan ShiDepartment of Hand Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.ORCID 0000-0002-1918-0975
Xingxing YuDepartment of Laboratory Medicine, Xi'an Medical College, Xi'an, Shaanxi, People's Republic of China.
Xuehai OuDepartment of Hand Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
Qian WangDepartment of Hand Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
Dong HuDepartment of Foot and Ankle Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral nerve injury remains a major clinical challenge due to inefficient axonal regeneration and limited therapeutic options. As central regulators of the repair process, macrophages dynamically transition from a pro-inflammatory to a pro-regenerative phenotype, coordinating debris clearance, axonal regrowth, remyelination, and functional restoration. However, disruptions in macrophage polarization-particularly in aging or chronic injury contexts-compromise regenerative outcomes. Here, we present a comprehensive overview of nano-immunomodulatory strategies designed to precisely direct macrophage fate for targeted peripheral nerve repair. Engineered organic, inorganic, and topography-guided nanoparticles provide spatiotemporal control of macrophage behavior via surface modifications and responsive designs, enabling phenotype reprogramming, microenvironment remodeling, and synergistic interactions with Schwann cells and regenerating axons. To present a balanced perspective, we also highlight key translational barriers-including long-term biocompatibility, immune safety, large-scale manufacturing, and regulatory challenges-that currently limit clinical application. This review highlights nano-immunomodulation as a promising approach for modulating immune-neural interfaces, offering a path toward precision therapies for peripheral nerve injury.

Indexed as

Immunologic FactorsMacrophagesNanoparticlesNerve RegenerationPeripheral Nerve InjuriesAnimalsHumansNanomedicinePeripheral NervesSchwann CellsImmunologic Factorsimmunemacrophagenanonedicineperipheral nerve injuryprecision therapy

Identifiers

PMID41847177
PMCPMC12990240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.